September 2020 – Ashvattha Therapeutics

Ashvattha Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

November 12, 2020September 10, 2020 by ashvatthaadmin

Jeffrey Cleland, Ph.D., chairman, chief executive officer and president of Ashvattha Therapeutics, will present at the virtual H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020.